Related references
Note: Only part of the references are listed.Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution
Jacob J. Mandel et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Walter Taal et al.
LANCET ONCOLOGY (2014)
CORRELATION OF MOLECULAR SUBTYPES WITH OVERALL SURVIVAL (OS) IN AVAGLIO, A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB (BEV) PLUS RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Heidi Phillips et al.
NEURO-ONCOLOGY (2014)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Definition of Primary and Secondary Glioblastoma
Hiroko Ohgaki et al.
CLINICAL CANCER RESEARCH (2013)
Gliosarcoma Metastatic to the Leptomeninges and Dura
Bobbak Mansouri et al.
JOURNAL OF NEUROIMAGING (2013)
Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features
Michael Karsy et al.
FOLIA NEUROPATHOLOGICA (2012)
Clinicopathologic and genomic features of gliosarcomas
Dakeun Lee et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
A study of clinico-pathological parameters and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma
Geetika Singh et al.
NEUROPATHOLOGY (2012)
Extra-Neural Metastases of Malignant Gliomas: Myth or Reality?
Patrick Beauchesne
Cancers (2011)
Clinical Characteristics and Outcomes for a Modern Series of Primary Gliosarcoma Patients
Seunggu J. Han et al.
CANCER (2010)
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2010)
Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity
Seunggu J. Han et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients Clinical article
Seunggu J. Han et al.
JOURNAL OF NEUROSURGERY (2010)
Secondary gliosarcoma: a review of clinical features and pathological diagnosis Clinical article
Seunggu J. Han et al.
JOURNAL OF NEUROSURGERY (2010)
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
Takuya Watanabe et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Ependymal tumors with sarcomatous change (ependymosarcoma): A clinicopathologic and molecular cytogenetic study
Fausto J. Rodriguez et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Gliosarcoma with multiple extracranial metastases: case report and review of the literature
Thomas L. Beaumont et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components
B Actor et al.
GENES CHROMOSOMES & CANCER (2002)
Genetic profile of gliosarcomas
RM Reis et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
